A carregar...
Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide
CONTEXT: Diazoxide, the only U.S. Food and Drug Administration–approved drug to treat hyperinsulinemic hypoglycemia, has been associated with several adverse events, which has raised concerns about the safety of this drug. Existing reports are limited to small studies and case reports. OBJECTIVE: To...
Na minha lista:
| Publicado no: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6207144/ https://ncbi.nlm.nih.gov/pubmed/30247666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-01613 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|